Glenn Pierce
InvestorInvestment Committee Co-Chair at Pathway to Cures
About
Pierce is an independent consultant and entrepreneur-in-residence at Third Rock Ventures with 30 years of biotech R&D experience. He retired from Biogen in 2014 as SVP of Hematology, Cell and Gene Therapies.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Haiyan Jiang
Scientific Advisory Group Member at Pathway to Cures
Frequently asked questions
- Who is Glenn Pierce?
- Pierce is an independent consultant and entrepreneur-in-residence at Third Rock Ventures with 30 years of biotech R&D experience. He retired from Biogen in 2014 as SVP of Hematology, Cell and Gene Therapies.
- Where does Glenn Pierce work?
- Glenn Pierce is Investment Committee Co-Chair at Pathway to Cures.